Kamada Ltd. (TLV:KMDA)
Israel
· Delayed Price · Currency is ILS · Price in ILA | Market Cap | 1.43B |
| Revenue (ttm) | 586.24M |
| Net Income (ttm) | 52.67M |
| Shares Out | 57.51M |
| EPS (ttm) | 0.91 |
| PE Ratio | 27.33 |
| Forward PE | n/a |
| Dividend | 0.73 (0.03%) |
| Ex-Dividend Date | Mar 17, 2025 |
| Volume | 17,146 |
| Average Volume | 129,015 |
| Open | 2,537.00 |
| Previous Close | 2,537.00 |
| Day's Range | 2,470.00 - 2,537.00 |
| 52-Week Range | 1,795.00 - 3,045.00 |
| Beta | 0.21 |
| RSI | 48.33 |
| Earnings Date | Mar 6, 2025 |
About Kamada
Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM f... [Read more]
Financial Performance
In 2024, Kamada's revenue was $160.95 million, an increase of 12.93% compared to the previous year's $142.52 million. Earnings were $14.46 million, an increase of 74.58%.
Financial numbers in USD Financial StatementsNews
Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas
REHOVOT, Israel and HOBOKEN, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for ...
Kamada Announces Dividend After Record-Breaking Year, Anticipates Further Double-Digit Growth
Despite significant advancements in medical technologies and pharmaceutical advancements, certain conditions can only be addressed via plasma-derived medicines . This is especially the case for many r...
Kamada Ltd. (KMDA) Q4 2024 Earnings Call Transcript
Kamada Ltd. (NASDAQ:KMDA) Q4 2024 Earnings Conference Call March 5, 2025 8:00 AM ETCompany ParticipantsBrian Ritchie – LifeSci AdvisorsAmir London – Chief...
Kamada declares $0.20 dividend
Kamada reports mixed Q4 results; reaffirms FY25 outlook
Kamada Reports Record Top and Bottom Line 2024 Financial Results and Affirms 2025 Guidance Representing Double-Digit Profitable Growth
REHOVOT, Israel, and HOBOKEN, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for...
Earnings Scheduled For March 5, 2025
Companies Reporting Before The Bell • Full Truck Alliance Co (NYSE: YMM) is projected to report quarterly earnings at $0.14 per share on revenue of $419.04 million. • Brown Forman Inc Class B Common ...
Kamada Q4 2024 Earnings Preview
Kamada to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 5, 2025
REHOVOT, Israel, and HOBOKEN, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd.
Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZIG® in Latin America
REHOVOT, Israel and HOBOKEN, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for r...
Gauzy Appoints Seasoned Public Company Executive and Director Lilach Payorski to Board of Directors
Possesses more than 25 years' multinational finance and operations experience across a range of industries Currently serves as board member of publicly traded companies Oddity Tech and Kamada Ltd. Bec...
Phoenix Financial Ltd. Increases Stake in Kamada Ltd.
Phoenix Financial Ltd. Increases Stake in Kamada Ltd.
Kamada Ltd. (KMDA) Q3 2024 Earnings Call Transcript
Call Start: 08:30 January 1, 0000 9:52 AM ETKamada Ltd.
Kamada GAAP EPS of $0.07 in-line, revenue of $41.74M beats by $0.69M
Kamada Reports Continued Profitable Growth with Strong Third Quarter and Nine Month 2024 Financial Results; Raises Full-Year Profitability Guidance
Revenues for Third Quarter of 2024 were $ 41.7 M illion , up 10 % Year-over-Year; Nine Month 2024 Total Revenues were $ 12 1 . 9 Million, u p 15 % Year -o ver - Year Third Quarter 2024 Adjusted EBITDA...
Earnings Scheduled For November 13, 2024
Companies Reporting Before The Bell • Davis Commodities (NASDAQ: DTCK) is expected to report earnings for its first quarter. • HIVE Digital Technologies (NASDAQ: HIVE) is estimated to report quarter...
What's Next: Kamada's Earnings Preview
Kamada (NASDAQ: KMDA) is set to give its latest quarterly earnings report on Wednesday, 2024-11-13. Here's what investors need to know before the announcement. Analysts estimate that Kamada will repo...
Kamada Q3 2024 Earnings Preview
Kamada expands plasma collection operations in Texas with new site in Houston
Kamada (KMDA) expands plasma collection operations with new Houston center, plans for San Antonio site.
Kamada Announces Expansion of Plasma Collection Operations in Texas with the Opening of New Site in Houston
REHOVOT, Israel and HOBOKEN, N.J., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for ...
Kamada Ltd. (KMDA) Q2 2024 Earnings Call Transcript
Kamada GAAP EPS of $0.08, revenue of $42.5M
Kamada Q2 2024 Earnings Preview
Kamada to Announce Second Quarter and First Half Ended June 30, 2024 Financial Results and Host Conference Call on August 14, 2024
REHOVOT, Israel, and HOBOKEN, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed produc...
Kamada Ltd. (KMDA) Q1 2024 Earnings Call Transcript
Kamada Ltd. (NASDAQ:KMDA) Q1 2024 Earnings Conference Call May 8, 2024 8:30 AM ET Company Participants Brian Ritchie - Investor Relations, LifeSci Advisors, LLC Amir London - Executive Officer Chaime...